DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors

Context:Temozolomide (TMZ) is an alkylating agent and was a first-line chemotherapeutic agent for malignant gliomas. Recently, TMZ has been documented to be effective against atypical pituitary adenomas (APAs) and pituitary carcinomas (PCs).Objective:The clinical and pathological characteristics of...

Full description

Saved in:
Bibliographic Details
Published inThe journal of clinical endocrinology and metabolism Vol. 98; no. 3; pp. 1130 - 1136
Main Authors Hirohata, Toshio, Asano, Kenichiro, Ogawa, Yoshikazu, Takano, Shingo, Amano, Kosaku, Isozaki, Osamu, Iwai, Yoshiyasu, Sakata, Kiyohiko, Fukuhara, Noriaki, Nishioka, Hiroshi, Yamada, Shozo, Fujio, Shingo, Arita, Kazunori, Takano, Koji, Tominaga, Atsushi, Hizuka, Naomi, Ikeda, Hidetoshi, Osamura, R. Yoshiyuki, Tahara, Shigeyuki, Ishii, Yudo, Kawamata, Takakazu, Shimatsu, Akira, Teramoto, Akira, Matsuno, Akira
Format Journal Article
LanguageEnglish
Published Bethesda, MD Oxford University Press 01.03.2013
Copyright by The Endocrine Society
Endocrine Society
Subjects
DNA
Online AccessGet full text

Cover

Loading…